GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Prescient Therapeutics Ltd (GREY:PSTTF) » Definitions » Cyclically Adjusted PB Ratio

Prescient Therapeutics (Prescient Therapeutics) Cyclically Adjusted PB Ratio : 1.32 (As of May. 04, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Prescient Therapeutics Cyclically Adjusted PB Ratio?

As of today (2024-05-04), Prescient Therapeutics's current share price is $0.145. Prescient Therapeutics's Cyclically Adjusted Book per Share for the fiscal year that ended in Jun23 was $0.11. Prescient Therapeutics's Cyclically Adjusted PB Ratio for today is 1.32.

The historical rank and industry rank for Prescient Therapeutics's Cyclically Adjusted PB Ratio or its related term are showing as below:

PSTTF' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 1.7
Current: 0.93

During the past 13 years, Prescient Therapeutics's highest Cyclically Adjusted PB Ratio was 1.70. The lowest was 0.00. And the median was 0.00.

PSTTF's Cyclically Adjusted PB Ratio is ranked better than
65.69% of 647 companies
in the Biotechnology industry
Industry Median: 1.75 vs PSTTF: 0.93

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Prescient Therapeutics's adjusted book value per share data of for the fiscal year that ended in Jun23 was $0.022. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.11 for the trailing ten years ended in Jun23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Prescient Therapeutics Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Prescient Therapeutics's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prescient Therapeutics Cyclically Adjusted PB Ratio Chart

Prescient Therapeutics Annual Data
Trend Jun13 Jun14 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 1.45

Prescient Therapeutics Semi-Annual Data
Dec13 Jun14 Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 1.45 -

Competitive Comparison of Prescient Therapeutics's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Prescient Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Prescient Therapeutics's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Prescient Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Prescient Therapeutics's Cyclically Adjusted PB Ratio falls into.



Prescient Therapeutics Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Prescient Therapeutics's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.145/0.11
=1.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prescient Therapeutics's Cyclically Adjusted Book per Share for the fiscal year that ended in Jun23 is calculated as:

For example, Prescient Therapeutics's adjusted Book Value per Share data for the fiscal year that ended in Jun23 was:

Adj_Book=Book Value per Share/CPI of Jun23 (Change)*Current CPI (Jun23)
=0.022/124.1700*124.1700
=0.022

Current CPI (Jun23) = 124.1700.

Prescient Therapeutics Annual Data

Book Value per Share CPI Adj_Book
201306 0.000 95.473 0.000
201406 0.098 98.352 0.124
201606 0.049 100.859 0.060
201706 0.042 102.809 0.051
201806 0.033 104.945 0.039
201906 0.025 106.617 0.029
202006 0.020 106.246 0.023
202106 0.024 110.332 0.027
202206 0.018 117.112 0.019
202306 0.022 124.170 0.022

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Prescient Therapeutics  (GREY:PSTTF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Prescient Therapeutics Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Prescient Therapeutics's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Prescient Therapeutics (Prescient Therapeutics) Business Description

Traded in Other Exchanges
Address
Level 4, 100 Albert Road, South Melbourne, Melbourne, VIC, AUS, 3205
Prescient Therapeutics Ltd is a clinical-stage oncology company. The company develops novel compounds for the treatment of a range of cancers in Australia. Its product in the pipeline includes OmniCAR; PTX-100 and PTX-200. OmniCAR is a universal immune receptor platform enabling controllable T-cell activity and multi-antigen targeting with a single cell product.